Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal –gastric varices

ConclusionsAtez/Bev might be an effective therapeutic option in patients with EGV, when appropriate endoscopic treatment for EGV is performed.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research